287 related articles for article (PubMed ID: 21207025)
1. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
[TBL] [Abstract][Full Text] [Related]
2. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
[TBL] [Abstract][Full Text] [Related]
3. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
López-Albaitero A; Nayak JV; Ogino T; Machandia A; Gooding W; DeLeo AB; Ferrone S; Ferris RL
J Immunol; 2006 Mar; 176(6):3402-9. PubMed ID: 16517708
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
5. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
[TBL] [Abstract][Full Text] [Related]
6. HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.
Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Wilson GM; Resnick LO; LaPorte MG; Wipf P; Huryn DM; Grandis JR
Assay Drug Dev Technol; 2015 Sep; 13(7):356-76. PubMed ID: 26317883
[TBL] [Abstract][Full Text] [Related]
7. Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53.
Kinney BLC; Gunti S; Kansal V; Parrish CJ; Saba NF; Teng Y; Henry MK; Su FY; Kwong GA; Schmitt NC
Cancer Immunol Immunother; 2024 Jan; 73(1):10. PubMed ID: 38231444
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
9. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
[TBL] [Abstract][Full Text] [Related]
10. STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.
Srivastava RM; Trivedi S; Concha-Benavente F; Hyun-Bae J; Wang L; Seethala RR; Branstetter BF; Ferrone S; Ferris RL
Cancer Immunol Res; 2015 Aug; 3(8):936-45. PubMed ID: 25972070
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling.
Cui B; Chen J; Luo M; Wang L; Chen H; Kang Y; Wang J; Zhou X; Feng Y; Zhang P
Int J Oncol; 2020 Apr; 56(4):909-920. PubMed ID: 32319563
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
Ferris RL; Hunt JL; Ferrone S
Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579
[TBL] [Abstract][Full Text] [Related]
13. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
14. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
[TBL] [Abstract][Full Text] [Related]
15. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
Wang W; Edington HD; Rao UN; Jukic DM; Land SR; Ferrone S; Kirkwood JM
Clin Cancer Res; 2007 Mar; 13(5):1523-31. PubMed ID: 17332298
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
[TBL] [Abstract][Full Text] [Related]
17. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
18. High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.
Johnston PA; Sen M; Hua Y; Camarco D; Shun TY; Lazo JS; Grandis JR
Assay Drug Dev Technol; 2014; 12(1):55-79. PubMed ID: 24127660
[TBL] [Abstract][Full Text] [Related]
19. Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
López-Albaitero A; Mailliard R; Hackman T; Andrade Filho PA; Wang X; Gooding W; Ferrone S; Kalinski P; Ferris RL
J Immunother; 2009 Jun; 32(5):465-73. PubMed ID: 19609238
[TBL] [Abstract][Full Text] [Related]
20. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
Ferris RL; Whiteside TL; Ferrone S
Clin Cancer Res; 2006 Jul; 12(13):3890-5. PubMed ID: 16818683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]